• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[缺血性卒中的止血异常]

[Hemostatic abnormalities in ischemic stroke].

作者信息

Misz M, Oláh L, Kappelmayer J, Blaskó G, Udvardy M, Fekete I, Csépány T, Ajzner E, Csiba L

机构信息

Debreceni Orvostudományi Egyetem Neurológiai Klinika, Klinikai Biokémiai és Molekuláris Patológiai Intézet.

出版信息

Orv Hetil. 1998 Oct 18;139(42):2503-7.

PMID:9810164
Abstract

The authors studied whether haemostatic abnormalities connected with the development of cerebral circulatory disturbances can be demonstrated in young stroke patients in whom Doppler and angiographic examination failed to reveal deviations indicative of stroke. They determined the in vivo activation of the coagulation system (TAT, F 1 + 2), the degree of secondary fibrinolysis (D-dimer), the plasma levels of the markers of fibrinolysis, with special regard to inhibitors: plasminogen activator inhibitor (PAI-1), alpha 2 antiplasmin (alpha 2 AP), alpha 2 macroglobulin (alpha 2 M), the frequency of pathologic serum lipoprotein (a)-Lp(a)-values and the association of PAI-1 and Lp(a) with the fibrinolytic system. They conclude that in the acute phase of the disease, the TAT and F 1 + 2 values were significantly elevated compared to the control, without change in the D-dimer value. The results suggest that in the tested period increased thrombin generation dominated and it significantly surpassed plasmin activity since the D-dimer values of that period did not indicate substantial increase in secondary fibrinolysis. The results of the study were separately analyzed in acute, chronic TIA and stroke groups. In the TIA and acute group the F 1 + 2 values, while in stroke the TAT values were more elevated. The in vitro fibrinolytic capacity of the patients significantly decreased compared to controls, showing significant correlation with the Lp(a) level, but not with the PAI value. Examination of the marker molecules renders possible to assess the degree of hypercoaguability and of endogenous lysis. Their knowledge is held important for judging the progression of the disease and the therapeutic consequences.

摘要

作者研究了在经多普勒和血管造影检查未发现提示中风的异常情况的年轻中风患者中,是否能证实存在与脑循环障碍发展相关的止血异常。他们测定了凝血系统的体内激活情况(凝血酶 - 抗凝血酶复合物、纤维蛋白肽A)、继发性纤溶程度(D - 二聚体)、纤溶标志物的血浆水平,特别关注抑制剂:纤溶酶原激活物抑制剂(PAI - 1)、α2抗纤溶酶(α2AP)、α2巨球蛋白(α2M)、病理性血清脂蛋白(a)-Lp(a)值的频率以及PAI - 1和Lp(a)与纤溶系统的关联。他们得出结论,在疾病急性期,与对照组相比,凝血酶 - 抗凝血酶复合物和纤维蛋白肽A值显著升高,而D - 二聚体值无变化。结果表明,在测试期间,凝血酶生成增加占主导,且显著超过纤溶酶活性,因为该时期的D - 二聚体值未表明继发性纤溶有实质性增加。研究结果分别在急性、慢性短暂性脑缺血发作(TIA)和中风组中进行了分析。在TIA和急性组中纤维蛋白肽A值升高,而在中风组中凝血酶 - 抗凝血酶复合物值升高更明显。与对照组相比,患者的体外纤溶能力显著降低,与Lp(a)水平显著相关,但与PAI值无关。对标志物分子的检测使得评估高凝程度和内源性纤溶程度成为可能。它们的信息对于判断疾病进展和治疗效果具有重要意义。

相似文献

1
[Hemostatic abnormalities in ischemic stroke].[缺血性卒中的止血异常]
Orv Hetil. 1998 Oct 18;139(42):2503-7.
2
Serial changes in fibrinolysis and coagulation activation markers in acute and convalescent phase of ischemic stroke.缺血性中风急性期和恢复期纤溶及凝血激活标志物的系列变化
Acta Neurol Scand. 2004 Oct;110(4):242-7. doi: 10.1111/j.1600-0404.2004.00304.x.
3
Alterations of haemostatic markers in various subtypes and phases of stroke.中风不同亚型和阶段止血标志物的改变。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):707-12.
4
Hemostasis during normal pregnancy and puerperium.正常妊娠和产褥期的止血。
Semin Thromb Hemost. 2003 Apr;29(2):125-30. doi: 10.1055/s-2003-38897.
5
Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia.急性脑缺血发作后很长时间,年轻患者出现高凝状态和炎症的证据。
Thromb Res. 2007;120(1):39-46. doi: 10.1016/j.thromres.2006.08.005. Epub 2006 Oct 10.
6
Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.患有和未患有缺血性心脏病的透析患者的凝血和纤维蛋白溶解因子
Adv Perit Dial. 2000;16:152-5.
7
Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.脓毒症中纤溶系统的激活及凝血抑制剂的利用:与严重脓毒症和脓毒性休克的比较
Intensive Care Med. 2001 Dec;27(12):1853-9. doi: 10.1007/s00134-001-1139-8. Epub 2001 Nov 10.
8
Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.冠状动脉、脑血管及外周动脉疾病中止血系统的激活产物
Thromb Haemost. 2001 Feb;85(2):234-9.
9
Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.早期抑制激活的纤溶系统可预测发热内科患者的微生物感染、休克及死亡率。
Thromb Haemost. 2001 Aug;86(2):543-9.
10
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.

引用本文的文献

1
Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension: A follow-up study.血管紧张素转换酶抑制对与早期高血压相关的动脉壁改变及认知功能可逆性的影响:一项随访研究。
Medicine (Baltimore). 2019 Aug;98(34):e16966. doi: 10.1097/MD.0000000000016966.